Cargando…

Effect of indacaterol on lung deflation improves cardiac performance in hyperinflated COPD patients: an interventional, randomized, double-blind clinical trial

BACKGROUND: COPD is often associated with cardiovascular comorbidity. Treatment guidelines recommend therapy with bronchodilators as first choice. We investigated the acute effect of single-dose indacaterol on lung hyperinflation in COPD subjects, for the first time evaluating the potential effects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santus, Pierachille, Radovanovic, Dejan, Di Marco, Silvia, Valenti, Vincenzo, Raccanelli, Rita, Blasi, Francesco, Centanni, Stefano, Bussotti, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574799/ https://www.ncbi.nlm.nih.gov/pubmed/26392766 http://dx.doi.org/10.2147/COPD.S91684

Ejemplares similares

A systematic review on tracheostomy decannulation: a proposal of a quantitative semiquantitative clinical score
por: Santus, Pierachille, et al.
Publicado: (2014)

Management of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide
por: Mantero, Marco, et al.
Publicado: (2018)

Pulmonary Rehabilitation in COPD: A Reappraisal (2008–2012)
por: Santus, Pierachille, et al.
Publicado: (2013)

The lungs need to be deflated: effects of glycopyrronium on lung hyperinflation in COPD patients
por: Sanguinetti, Claudio M
Publicado: (2014)

The Airways' Mechanical Stress in Lung Disease: Implications for COPD Pathophysiology and Treatment Evaluation
por: Santus, Pierachille, et al.
Publicado: (2019)

Role of nebulized glycopyrrolate in the treatment of chronic obstructive pulmonary disease
por: Santus, Pierachille, et al.
Publicado: (2017)

The evidence on tiotropium bromide in asthma: from the rationale to the bedside
por: Radovanovic, Dejan, et al.
Publicado: (2017)

Erratum to: The evidence on tiotropium bromide in asthma: from the rationale to the bedside
por: Radovanovic, Dejan, et al.
Publicado: (2017)

Diagnostic Insights from Plethysmographic Alveolar Pressure Assessed during Spontaneous Breathing in COPD Patients
por: Zilianti, Camilla, et al.
Publicado: (2021)

Plethysmographic Loops: A Window on the Lung Pathophysiology of COPD Patients
por: Radovanovic, Dejan, et al.
Publicado: (2018)

Acute Improvements of Oxygenation with Cpap and Clinical Outcomes in Severe COVID-19 Pneumonia: A Multicenter, Retrospective Study
por: Pini, Stefano, et al.
Publicado: (2022)

Efficacy of tiotropium and indacaterol monotherapy and their combination on dynamic lung hyperinflation in COPD: a random open-label crossover study
por: Fujimoto, Keisaku, et al.
Publicado: (2017)

Sublobar resection: functional evaluation and pathophysiological considerations
por: Santus, Pierachille, et al.
Publicado: (2020)

Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study
por: Viecca, Maurizio, et al.
Publicado: (2020)

Mucins and Asthma: Are We Headed to the Revolutionary Road?
por: Santus, Pierachille, et al.
Publicado: (2019)

Helmet CPAP to Treat Acute Hypoxemic Respiratory Failure in Patients with COVID-19: A Management Strategy Proposal
por: Radovanovic, Dejan, et al.
Publicado: (2020)

Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis
por: Blasi, Francesco, et al.
Publicado: (2007)

Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease - a randomized, multicenter, double-blind, placebo-controlled study
por: Watz, Henrik, et al.
Publicado: (2014)

The effect of a multidisciplinary approach for smoking cessation in patients with Crohn’s disease: Results from an observational cohort study
por: Santus, Pierachille, et al.
Publicado: (2020)

Characteristics and outcomes in hospitalized COVID-19 patients during the first 28 days of the spring and autumn pandemic waves in Milan: An observational prospective study
por: Radovanovic, Dejan, et al.
Publicado: (2021)

Predictors of weaning from helmet CPAP in patients with COVID-19 pneumonia
por: Radovanovic, Dejan, et al.
Publicado: (2021)

Hyperinflation and its management in COPD
por: Puente-Maestu, Luis, et al.
Publicado: (2006)

Cardiovascular effects of exercise induced dynamic hyperinflation in COPD patients—Dynamically hyperinflated and non-hyperinflated subgroups
por: Lukacsovits, Jozsef, et al.
Publicado: (2023)

Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis
por: Di Marco, Fabiano, et al.
Publicado: (2018)

Safety of indacaterol in the treatment of patients with COPD
por: Donohue, James F, et al.
Publicado: (2011)

Correction to: Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis
por: Di Marco, Fabiano, et al.
Publicado: (2018)

Avoiding misdiagnosis in patients with dyspnea and wheezing: a case report illustrating the clinical implications of fixation error
por: Di Marco, Fabiano, et al.
Publicado: (2017)

Longitudinal changes in lung hyperinflation in COPD
por: Park, Jimyung, et al.
Publicado: (2017)

Effects of indacaterol/glycopyrronium (QVA149) on lung hyperinflation and physical activity in patients with moderate to severe COPD: a randomised, placebo-controlled, crossover study (The MOVE Study)
por: Watz, Henrik, et al.
Publicado: (2016)

Patients beliefs on intravenous and subcutaneous routes of administration of biologics for severe asthma treatment: A cross-sectional observational survey study
por: Santus, Pierachille, et al.
Publicado: (2019)

Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD—a randomised controlled study
por: Salomon, Joerg, et al.
Publicado: (2017)

Feasibility and Clinical Outcomes of a Step Up Noninvasive Respiratory Support Strategy in Patients with Severe COVID-19 Pneumonia
por: Coppola, Silvia, et al.
Publicado: (2021)

The role of phenotype on ventilation and exercise capacity in patients affected by COPD: a retrospective study
por: Rinaldo, Rocco F., et al.
Publicado: (2020)

Predictors of Helmet CPAP Failure in COVID-19 Pneumonia: A Prospective, Multicenter, and Observational Cohort Study
por: Santus, Pierachille, et al.
Publicado: (2022)

Efficacy and safety of indacaterol 150 μg once-daily in COPD: a double-blind, randomised, 12-week study
por: Feldman, Gregory, et al.
Publicado: (2010)

Resting hyperinflation and emphysema on the clinical course of COPD
por: Kim, Yeon Wook, et al.
Publicado: (2019)

No room to breathe: the importance of lung hyperinflation in COPD
por: Thomas, Mike, et al.
Publicado: (2013)

How air pollution influences clinical management of respiratory diseases. A case-crossover study in Milan
por: Santus, Pierachille, et al.
Publicado: (2012)

Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium
por: Vogelmeier, Claus, et al.
Publicado: (2010)

Trends over Time of Lung Function and Radiological Abnormalities in COVID-19 Pneumonia: A Prospective, Observational, Cohort Study
por: Santus, Pierachille, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7b3apomuoi9l6tap70jbg3gl18